IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Cardiovascular Drugs and Therapy

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

3.23

h-Index

2024-2025

 83

Rank

2024-2025

 4814

SJR

2024-2025

 1.002

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Cardiovascular Drugs and Therapy
Abbreviation Cardiovasc. Drugs Ther.
Publication Type Journal
Subject Area, Categories, Scope Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)
h-index 83
Overall Rank/Ranking 4814
SCImago Journal Rank (SJR) 1.002
Impact Score 3.23
Publisher Springer
Country United States
ISSN 15737241, 09203206
Best Quartile Q1
Coverage History 1987-2025




About Cardiovascular Drugs and Therapy


Cardiovascular Drugs and Therapy is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2). It is published by Springer. The overall rank of Cardiovascular Drugs and Therapy is 4814. According to SCImago Journal Rank (SJR), this journal is ranked 1.002. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 83. The best quartile for this journal is Q1.

The ISSN of Cardiovascular Drugs and Therapy journal is 15737241, 09203206. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cardiovascular Drugs and Therapy is cited by a total of 1207 articles during the last 3 years (Preceding 2024).


Cardiovascular Drugs and Therapy Impact IF 2024-2025


The Impact IF 2024 of Cardiovascular Drugs and Therapy is 3.23, which is computed in 2025 as per its definition. Cardiovascular Drugs and Therapy IF is increased by a factor of 0.1 and approximate percentage change is 3.19% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Cardiovascular Drugs and Therapy Impact IF 2025 Prediction


Impact IF 2024 of Cardiovascular Drugs and Therapy is 3.23. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Cardiovascular Drugs and Therapy. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 3.23
2023 3.13
2022 3.59
2021 3.33
2020 2.83
2019 3.65
2018 3.91
2017 2.66
2016 2.54
2015 2.82
2014 2.82

Cardiovascular Drugs and Therapy h-index


  Table Setting

Cardiovascular Drugs and Therapy has an h-index of 83. It means 83 articles of this journal have more than 83 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Cardiovascular Drugs and Therapy ISSN


The ISSN of Cardiovascular Drugs and Therapy is 15737241, 09203206. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Cardiovascular Drugs and Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Cardiovascular Drugs and Therapy is 4814. According to SCImago Journal Rank (SJR), this journal is ranked 1.002. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Cardiovascular Drugs and Therapy by Year


Year SJR
2025/2026 Coming Soon
2024 1.002
2023 0.973
2022 0.913
2021 0.860
2020 1.108
2019 1.360
2018 1.338
2017 1.349
2016 1.067
2015 1.238
2014 1.222

Ranking of Cardiovascular Drugs and Therapy by Year


Year Ranking
2025/2026 Coming Soon
2024 4814
2023 4649
2022 4882
2021 5141
2020 3748
2019 2641
2018 2737
2017 2749
2016 4008
2015 3248
2014 3231

Cardiovascular Drugs and Therapy Publisher


Table Setting

Cardiovascular Drugs and Therapy is published by Springer. It's publishing house is located in United States. Coverage history of this journal is as following: 1987-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Cardiovascular Drugs and Therapy is Cardiovasc. Drugs Ther.. This abbreviation ('Cardiovasc. Drugs Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Cardiovascular Drugs and Therapy


If your research field is/are related to Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Cardiovascular Drugs and Therapy?

Cardiovascular Drugs and Therapy latest impact IF is 3.23. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.91 (2018) and 2.54 (2016), respectively, in the last 11 years. Moreover, its average IS is 3.14 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Cardiovascular Drugs and Therapy?

The Cardiovascular Drugs and Therapy has an SJR (SCImago Journal Rank) of 1.002, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.360 in 2019 and the lowest being 0.860 in 2021. Furthermore, the average SJR of the Cardiovascular Drugs and Therapy over the previous 11-year period stands at 3.14.


What's the latest h-index of the Cardiovascular Drugs and Therapy?

The latest h-index of the Cardiovascular Drugs and Therapy is 83.


Who's the publisher of the Cardiovascular Drugs and Therapy?

The Cardiovascular Drugs and Therapy is published by the Springer, with its country of publication being the United States.


What's the current ranking of the Cardiovascular Drugs and Therapy?

The Cardiovascular Drugs and Therapy is currently ranked 4814 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 2641 in 2019 and its lowest position of 5141 in 2021.


What's the abbreviation or short name for the Cardiovascular Drugs and Therapy?

The standard ISO4 abbreviation for the Cardiovascular Drugs and Therapy is Cardiovasc. Drugs Ther..


Is the "Cardiovascular Drugs and Therapy" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Cardiovascular Drugs and Therapy is classified as a journal that the Springer publishes.


What's the scope or major areas of the Cardiovascular Drugs and Therapy?

The Cardiovascular Drugs and Therapy encompasses the following areas:

  • Cardiology and Cardiovascular Medicine
  • Medicine (miscellaneous)
  • Pharmacology (medical)
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Cardiovascular Drugs and Therapy?

The Cardiovascular Drugs and Therapy is assigned the following International Standard Serial Numbers (ISSN): 15737241, 09203206.


What's the best quartile of the Cardiovascular Drugs and Therapy?

The best quartile for the Cardiovascular Drugs and Therapy is Q1 (2024).


What's the coverage history of the Cardiovascular Drugs and Therapy?

The Cardiovascular Drugs and Therapy coverage history can be summarized as follows: 1987-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Dermatologia Kliniczna journal 25442 Cornetis 7 0.00
European Union Politics journal 1953 SAGE Publications Ltd 79 3.71
Journal of Field Archaeology journal 7683 Maney Publishing 48 1.85
Marine Biology Research journal 14618 Taylor and Francis Ltd. 47 1.21
International Journal of Research and Method in Education journal 6367 Taylor and Francis Ltd. 41 3.31
Palaeontographica Abteilung B: Palaeophytologie book series 10600 Schweizerbart Science Publishers 18 4.25
European Surgery - Acta Chirurgica Austriaca journal 18136 Springer Medizin 25 0.68
Tekstilec trade journal 17340 University of Ljubljana Press 16 1.29
Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria journal 25905 National Association of Resident Doctors of Nigeria 25 0.00
Canadian Journal of Mathematics journal 7806 Canadian Mathematical Society 48 0.98

Check complete list




Year wise Impact Score (IS) of Cardiovascular Drugs and Therapy

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 3.23
2023 3.13
2022 3.59
2021 3.33
2020 2.83
2019 3.65
2018 3.91
2017 2.66
2016 2.54
2015 2.82
2014 2.82



Top Journals/Conferences in Cardiology and Cardiovascular Medicine

Nature Reviews Cardiology
Nature Research | United Kingdom

Journal of the American College of Cardiology
Elsevier Inc. | United States

Circulation
Lippincott Williams and Wilkins | United States

JAMA Cardiology
American Medical Association | United States

European Journal of Heart Failure
John Wiley and Sons Ltd | United Kingdom

JACC: Cardiovascular Imaging
Elsevier Inc. | United States

JACC: Heart Failure
Elsevier Inc. | United States

European Heart Journal
Oxford University Press | United Kingdom

Circulation Research
Lippincott Williams and Wilkins | United States

Nature Cardiovascular Research
Springer | Germany

See All

Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Research | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Nature Medicine
Nature Research | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

Physiological Reviews
American Physiological Society | United States

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All